French Healthtech Stock News

On 5 January 2026, Capgemini’s Board accepted the resignation of director Megan Clarken and, by co-option, appointed AI specialist Lila Tretikov, Head of AI Strategy at New Enterprise Associates and former Microsoft Corporate Vice President & Deputy CTO. Tretikov’s appointment brings deep Artificial Intelligence and technology-transformation expertise onto Capgemini’s Board, potentially influencing how the group shapes its technology, innovation and governance priorities. We’ll now examine...

Vallourec recently reported trading in its own shares between January 8 and 9, 2026 under its ongoing shareholder-approved buyback program, while also securing a major contract with Shell to supply OCTG products, VAM® premium connections and associated services for the Orca offshore project in Brazil. The Shell Orca award reinforces Vallourec’s role in high-spec offshore tubular solutions and services, highlighting the breadth of its premium value-chain offering in Brazil’s deepwater...

Mercialys (ENXTPA:MERY) is drawing investor attention after recent share price moves, with the stock last closing at €10.64. That price now appears alongside fresh fundamentals data on revenue and earnings. See our latest analysis for Mercialys. Recent trading has been fairly muted, with a 1 day share price return of a 1.66% decline, a 30 day share price return of 1.33% and a year to date share price return close to flat. By contrast, the 1 year total shareholder return of 15.58% and 5 year...

Eutelsat recently awarded Airbus Defence and Space a contract to build 340 additional OneWeb low Earth orbit satellites in Toulouse, while Airbus also reported 793 commercial aircraft deliveries in 2025 and a record backlog of 8,754 planes. This combination of a large, long-dated satellite order and a historically high aircraft backlog underscores how diversified demand is shaping Airbus’s workload. We’ll now explore how this major OneWeb satellite contract, alongside record aircraft...

Planisware SAS (ENXTPA:PLNW) has caught investor attention after recent share price moves, with the stock showing mixed short term returns and a stronger performance over the past 3 months. See our latest analysis for Planisware SAS. The recent pullback in Planisware SAS, with a 1-day share price return of 0.44% decline and a 7-day share price return of 1.72% decline at a €22.85 share price, sits alongside a 30-day share price return of 8.29% and a 90-day share price return of 15.99%. The...

Edenred recently issued a €500 million bond maturing in January 2033 with a 3.75% coupon, attracting demand of over €1.60 billion from international institutional investors and using the proceeds mainly to refinance a bond due in March 2026. This oversubscribed issue extends Edenred’s average bond maturity to 4.1 years and underpins funding for its Amplify25-28 growth plan. Next, we’ll examine how this strongly oversubscribed €500 million bond issue may influence Edenred’s investment...

UBS’s move to downgrade Ipsen (ENXTPA:IPN) to neutral, citing the looming patent expiry of its oncology drug Cabometyx, has pushed the company’s revenue resilience and oncology focus into sharper focus for investors. See our latest analysis for Ipsen. Against UBS’s downgrade, Ipsen’s €129.3 share price sits on the back of an 11.37% year to date share price return. The 5 year total shareholder return of 93.01% points to momentum that has so far been resilient rather than accelerating. If you...

L'Oréal (ENXTPA:OR) is back in the spotlight after its CES 2026 showcase of AI powered beauty tech, including the Light Straight + Multi Styler and a flexible LED Face Mask that both received CES Innovation Awards. See our latest analysis for L'Oréal. Against this backdrop, L'Oréal's share price has moved to €392.4, with a 7-day share price return of 8.01% and a year to date share price return of 7.60%. Its 1-year total shareholder return of 21.65% points to building momentum supported by CES...

Bureau Veritas (ENXTPA:BVI) is back in focus after recent share price moves, with the stock showing mixed returns across different periods and attracting attention from investors who are reassessing its testing, inspection, and certification business. See our latest analysis for Bureau Veritas. Recent moves have been mixed, with a 4.5% 1 month share price return and a small year to date gain. However, the 1 year total shareholder return of a 5.9% decline suggests momentum has softened...

In early January 2026, Michelin’s Supervisory Board and SAGES renewed Florent Menegaux’s term as Managing General Partner for four years and decided to propose Philippe Jacquin as General Manager at the next Shareholders Meeting. This leadership continuity, combined with a planned new General Manager, underscores the board’s confidence in current management as Michelin pursues its long-term development priorities. We’ll now examine how Florent Menegaux’s renewed mandate and Philippe...

Key Insights Wavestone's significant insider ownership suggests inherent interests in company's expansion The top 4...

Virbac (ENXTPA:VIRP) has been drawing attention after recent share price moves, with the stock showing mixed short term returns and stronger performance over the past 3 months and year for long term holders. See our latest analysis for Virbac. Recent trading has been choppy, with a 1 day share price return of a 1.51% decline and a flat 7 day move. However, the 90 day share price return of 16.59% and 1 year total shareholder return of 14.69% suggest that momentum has been building rather than...

Amid optimism about the European economy and favorable interest rate conditions, major stock indexes across the region have experienced gains, with Germany's DAX and France's CAC 40 Index showing notable increases. In this environment of strengthening economic indicators, identifying stocks that may be priced below their intrinsic value can offer strategic opportunities for investors seeking to capitalize on potential market inefficiencies.

By buying an index fund, investors can approximate the average market return. But if you choose individual stocks with...

The Gold By Gold SA ( EPA:ALGLD ) share price has done very well over the last month, posting an excellent gain of 28...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

Exail Technologies ( EPA:EXA ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Quadient fair value estimate is €12.87 Quadient's €16.16 share...

Exosens (ENXTPA:EXENS) has been in focus after announcing its largest contract yet for 5G image intensifier tubes, supplying more than 7,000 units to ACTinBlack Group for European Special Forces night vision systems. See our latest analysis for Exosens. The new 5G night vision contract and Theon International’s recent €54 per share stake purchase sit alongside a liquidity contract update, and together coincide with a 30 day share price return of 22.55% and a 1 year total shareholder return of...

The latest movement in Sanofi (ENXTPA:SAN) has been influenced by a European Commission approval for Teizeild, the first EU-cleared disease-modifying therapy intended to delay stage 3 type 1 diabetes in eligible patients. See our latest analysis for Sanofi. Despite the recent Teizeild approval and other pipeline updates, Sanofi’s share price, which last closed at €82.41, has moved only modestly, with a near flat year to date share price return and a 1 year total shareholder return decline...

BNP Paribas (ENXTPA:BNP) has drawn fresh investor attention after multiple global banks upgraded the stock, citing stronger profitability prospects, solid capital generation, and the bank’s plan to return surplus capital to shareholders. See our latest analysis for BNP Paribas. At a share price of €87.24, BNP Paribas has seen short term momentum pick up, with a 7 day share price return of 6.56% and a 90 day share price return of 15.17%. Its 1 year total shareholder return of 60.99% and 5 year...

If you are wondering whether Airbus is fairly priced at around €215.10, or if recent enthusiasm has pushed it ahead of its fundamentals, this article is for you. Airbus shares recently closed at €215.10, with returns of 3.4% over 7 days, 10.9% over 30 days, 5.6% year to date, 41.5% over 1 year, 96.8% over 3 years and 152.4% over 5 years. These figures raise a clear question about what is already reflected in the price. Recent attention on Airbus has focused on its position in global...

Atos recently announced a partnership with the World DanceSport Federation (WDSF) to drive digital innovation in DanceSport, including ticketing, competition services and fan engagement for major events such as the 2025 and 2026 WDSF DanceSport Festivals in Blackpool and the 2026 Brisbane World Breaking DanceSport Festival. An early deployment of Atos’ customized ticketing and distribution platform for the 2025 WDSF DanceSport Festival led to a very large jump in tickets sold within 12...

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...